PubRank

Igor S Lukashevich

Author PubWeight™ 17.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Cell Host Microbe 2008 1.31
2 Early blood profiles of virus infection in a monkey model for Lassa fever. J Virol 2007 1.20
3 A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine 2007 1.13
4 A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol 2010 1.10
5 A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology 2006 1.06
6 Past, present, and future of arenavirus taxonomy. Arch Virol 2015 1.00
7 The proline-rich homeodomain (PRH/HEX) protein is down-regulated in liver during infection with lymphocytic choriomeningitis virus. J Virol 2005 0.92
8 Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. Vaccine 2010 0.90
9 Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. Vaccine 2012 0.89
10 Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever. Antiviral Res 2011 0.88
11 Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever. J Med Virol 2004 0.88
12 Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses. Virus Genes 2006 0.88
13 An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity. Virol J 2013 0.86
14 Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro. J Virol 2012 0.86
15 Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate. PLoS Negl Trop Dis 2013 0.85
16 Circulating natural killer and gammadelta T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus. Mem Inst Oswaldo Cruz 2009 0.85
17 Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model. Vaccine 2012 0.79
18 Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers. J Vaccines Vaccin 2012 0.79
19 Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate. J Virol 2013 0.76